News and Trends 21 Jan 2022
Two Gene Therapy Players Launch IPOs on Stormy Stock Market
After a drought of more than a year, the European gene therapy sector saw initial public offerings from Genenta Science…
IPO
- Latest Posts
News and Trends 10 Nov 2021
Evotec IPO Hints At Stabilizing Investor Interest In Biotech Stocks
German life sciences heavyweight Evotec raised around €376M ($435M) in its US debut on the Nasdaq last week, fueling tentative…
News and Trends 15 Oct 2021
Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO
Oxford Nanopore Technologies, until recently one of very few unicorns in the European biotech industry, had a stellar IPO on…
News and Trends 7 Oct 2021
Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery
Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts to use artificial intelligence to…
ADVERTISEMENT
News and Trends 25 May 2021
Delayed IPOs and Market Drops Batter Biotech Stocks
Stock markets worldwide have experienced painful instability in the last few months. As a result, the European biotech market has…
News and Trends 20 Apr 2021
Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions
The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in the latest of a series…
News and Trends 31 Mar 2021
Lava Therapeutics’ IPO Shakes Cancer Niche of Gamma Delta T Cells
The Dutch biotech startup Lava Therapeutics launched onto the Nasdaq stock market last week with an €85.6M ($100.5M) IPO. This…
Expert Advice 26 Oct 2020
How to Prepare for a Successful Biotech IPO
Any biotech company that has reached a certain size and is in need of investment will have to consider the…
News and Trends 15 May 2020
Update: ADC Therapeutics’ IPO Hits Above Target with €215M
Update (15/05/2020): The Swiss biotech ADC Therapeutics has priced its IPO on the New York Stock Exchange far above the…
News and Trends 7 Nov 2019
€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics
The German company Centogene has raised €50.6M ($56M) in an IPO on the Nasdaq Stock Exchange to fund the development…
News and Trends 17 Oct 2019
Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer
The French company Innate Pharma has raised a Nasdaq IPO of €62.1M ($68.8M) to fund the development of antibody immunotherapies…
News and Trends 4 Oct 2019
ADC Therapeutics Cancels Nasdaq IPO Amidst Market Growth Fears
The Swiss biotech ADC Therapeutics has withdrawn its application for a €182M ($200M) Nasdaq IPO, citing adverse market conditions caused…
News and Trends 18 Jul 2019
Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs
The Danish biotech Genmab has made a big splash on the Nasdaq, raising a €450M ($506M) IPO to fuel its…
20 May 2019
What’s New on the European Biotech Market?
All over the world, the life sciences industry is booming. Biotechnology, in particular, is experiencing a golden age. By 2024,…
News and Trends 13 Nov 2018
Are Recent IPO Delays Bad News for European Biotech?
Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs on the stock markets --…
News and Trends 18 Oct 2017
Biotech Crosses the Channel to Raise €9.7M for its Diagnostics Tools
Novacyt will use the money raised on the AIM market, London, to expand its manufacturing capacity and continue research looking…
ADVERTISEMENT
News and Trends 4 Oct 2017
Ablynx Launches $175M IPO on Wall Street After Phase III Success
Fresh from announcing positive Phase III results, Ablynx has wasted no time in filing a $175M (€148M) IPO to continue…
News and Trends 7 Sep 2017
Scottish Oncology Biotech Aims for €96M IPO in the Nasdaq
Nucana Biomed has filed for a Nasdaq IPO in which it expects to raise up to $115M (€96M) to support…
News and Trends 4 Sep 2017
British Biotech Developing New Antibiotics Enters the London Stock Exchange
Destiny Pharma has started trading on the London Stock Exchange to support its search for new antibiotics that can fight…
News and Trends 9 Aug 2017
Danish Diabetes Biotech Rakes in $75M on NASDAQ in American IPO
After announcing its intentions last month, Zealand Pharma has gone public in the US to fund its diabetes clinical trials.…
